Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 248.83M
March 31, 2026 314.48M
December 31, 2025 321.03M
September 30, 2025 338.90M
June 30, 2025 244.17M
March 31, 2025 228.01M
December 31, 2024 231.90M
September 30, 2024 231.36M
June 30, 2024 228.99M
March 31, 2024 228.53M
December 31, 2023 239.71M
September 30, 2023 162.31M
June 30, 2023 158.97M
March 31, 2023 159.33M
December 31, 2022 158.93M
September 30, 2022 158.27M
June 30, 2022 162.24M
March 31, 2022 167.43M
December 31, 2021 163.78M
September 30, 2021 165.83M
June 30, 2021 161.64M
March 31, 2021 144.57M
December 31, 2020 106.54M
September 30, 2020 101.41M
June 30, 2020 98.32M
Date Value
March 31, 2020 98.92M
December 31, 2019 98.39M
September 30, 2019 101.04M
June 30, 2019 93.48M
March 31, 2019 83.16M
December 31, 2018 109.52M
September 30, 2018 73.15M
June 30, 2018 73.75M
March 31, 2018 77.56M
December 31, 2017 104.03M
September 30, 2017 76.09M
June 30, 2017 82.60M
March 31, 2017 27.38M
December 31, 2016 27.96M
September 30, 2016 32.26M
June 30, 2016 32.47M
March 31, 2016 32.39M
December 31, 2015
September 30, 2015 33.24M
June 30, 2015 33.97M
March 31, 2015 35.73M
December 31, 2014 36.92M
September 30, 2014 39.89M
June 30, 2014 44.13M
March 31, 2014 44.36M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 45.33M
Healios KK 53.98M
AnGes, Inc. 1.266M
ACADIA Pharmaceuticals, Inc. 1.307B
Alkermes Plc 1.809B

Shareholders Equity (Quarterly) Related Metrics